National Medical Care Company
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from National Medical Care Company's yearly results (2022–2025), compared with Healthcare companies in Saudi Arabia. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Cash, after subtracting all debt, equals 0% of its market value (net cash). Higher than 88% of Healthcare companies in Saudi Arabia.
Where SAR 100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
SAR 101Over the last 3 years, every SAR 100 of reported profit came with SAR 101 of operating cash.
Lower than 71% of Healthcare companies in Saudi Arabia.
Self-Funding Ratio
2.0×Over the last 3 years its own operating cash covered its investment spending (capex) 2.0 times.
Lower than 62% of Healthcare companies in Saudi Arabia.
Cash Locked Ratio
SAR 49For every SAR 100 of sales, SAR 49 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against SAR 71 tied up three years earlier.
More money tied up than 62% of Healthcare companies in Saudi Arabia.
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 75% of Healthcare companies in Saudi Arabia.
Growth Efficiency Ratio
SAR 22Sales grew 74% in 3 years; of every extra SAR 100 of sales, SAR 22 became extra profit.
Higher than 62% of Healthcare companies in Saudi Arabia.
Asset Productivity Ratio
+74% / +62%In 3 years sales changed by +74% while total assets changed by +62%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
2.8×Debt due within a year is covered 2.8 times by its yearly operating cash.
Higher than 62% of Healthcare companies in Saudi Arabia.
Cash Cushion Ratio
+0%Cash, after subtracting all debt, equals 0% of its market value (net cash).
Higher than 88% of Healthcare companies in Saudi Arabia.
Tangible Assets Ratio
95%Of every SAR 100 the company owns, SAR 95 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 77% of Healthcare companies in Saudi Arabia.
Tangible Net Worth Ratio
92%Of every SAR 100 of net worth, SAR 92 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 68% of Healthcare companies in Saudi Arabia.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
National Medical Care Company owes SAR 0.39 for every SAR 1 it owns. Net profit rose 8% in the year to Dec 2025, and grew 23% a year on average over 3 years.
Compared with Healthcare companies in Saudi Arabia · latest annual results Dec 2025.
P/E ratio
13.6Investors pay SAR 13.6 for every SAR 1 of National Medical Care Company's yearly profit, lower than 88% of Healthcare companies in Saudi Arabia.
P/B ratio
2.19The share price is 2.19 times National Medical Care Company's book value per share, higher than 54% of Healthcare companies in Saudi Arabia.
Market cap
SAR 4.1 BThe total market value of all of National Medical Care Company's shares at today's price (share price × number of shares), smaller than 54% of Healthcare companies in Saudi Arabia. PosiCap size class: Meso Cap.
Net worth (book value)
SAR 1.9 BWhat National Medical Care Company would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
SAR 41.68Net worth divided by the number of shares. The share price of SAR 91.20 is 2.2 times this, which is the P/B above.
Return on equity (ROE)
16.8%National Medical Care Company earned 16.8% on its shareholders' money over the last year, higher than 59% of Healthcare companies in Saudi Arabia.
Owes vs Owns
0.39×National Medical Care Company owes SAR 0.39 for every SAR 1 it owns (low), lower than 71% of Healthcare companies in Saudi Arabia.
Dividend yield
3.44%National Medical Care Company pays 3.44% of its share price as dividends a year, lower than 54% of dividend-paying Healthcare companies in Saudi Arabia.
Revenue growth
+24%Revenue rose 24% in the year to Dec 2025, and grew 20% a year on average over 3 years.
Profit growth
+8%Net profit rose 8% in the year to Dec 2025, and grew 23% a year on average over 3 years.
Profit margin
19.9%National Medical Care Company keeps SAR 20 of every SAR 100 of revenue as net profit.
Cash quality
0.5×Cash from National Medical Care Company's business was 0.5× its reported profit in the year to Dec 2025 — less cash came in than the profit reported.
Interest cover
13.1×National Medical Care Company's operating profit covered its interest costs 13.1 times in the year to Dec 2025.
Cash vs debt
Net cashNational Medical Care Company held SAR 15 M more cash than debt (net cash) at Dec 2025.
Questions
What is National Medical Care Company's P/E ratio?
Investors pay SAR 13.6 for every SAR 1 of National Medical Care Company's yearly profit, lower than 88% of Healthcare companies in Saudi Arabia.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For National Medical Care Company: SAR 4.1 B ÷ SAR 1.9 B (30 Jun 2026) = 2.2.
What is National Medical Care Company's return on equity?
National Medical Care Company earned 16.8% on its shareholders' money over the last year, higher than 59% of Healthcare companies in Saudi Arabia.
How much does National Medical Care Company owe compared with what it owns?
National Medical Care Company owes SAR 0.39 for every SAR 1 it owns (low), lower than 71% of Healthcare companies in Saudi Arabia.
Does National Medical Care Company pay a dividend?
Yes. National Medical Care Company pays 3.44% of its share price as dividends a year, lower than 54% of dividend-paying Healthcare companies in Saudi Arabia.
Is National Medical Care Company's revenue growing?
Revenue rose 24% in the year to Dec 2025, and grew 20% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.